Skip to content

Role of Hridya Mahakashaya churna in Hridroga (CHF) patients

Evaluation of Hridya Mahakashaya churna in Hridroga (CHF)and its relation with Prakriti and Agnibala - NIL

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/070457
Enrollment
70
Registered
2024-07-11
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I502- Systolic (congestive) heart failure

Interventions

None listed

Sponsors

Dr Ragini Joshi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects of either sex belonging to age between 40 to 60 years ,diagnosis of heart failurefor at least 2 months are eligible, if they are fulfilling the criteria described in New York Heart Association (NYHA) functional class II or class III i.e mild or moderate patients,have a left ventricular ejection fraction documented to be = 40% within the last 12 months are taken. Volunteers willing to be the part of the study by giving written consent in prescribed format.

Exclusion criteria

Exclusion criteria: The patients with age below 40 years and above 60 years. Patients coming under the criteria described in New York Heart Association (NYHA) functional class IV i.e severe patients of heart failure Patients with known case of Myocadial Infaction (MI) Volunteers having any type of recurrent or chronic illness History of any known disease/illness, tuberculosis, malignancy, severe anemia or any other acute disease.

Design outcomes

Primary

MeasureTime frame
The effect of Hridya Mahakashaya on Hridroga patients has relation with Prakriti and Agnibala. And it will assessed by Objective parameters like Electrocardiogram, Echocardiogram of patients on the follow ups and by subjective parameters like filling the standard proforma for prakriti and agnibala before and after the intervention. Timepoint: Evaluation will be done after 6 months

Secondary

MeasureTime frame
The prevalence of Hridroga depend upon the Prakriti & Agnibala of an individual.it will be assessed by filling valid proforma for prakriti & agnibala before the intervention in the patients.Timepoint: 3 months

Countries

India

Contacts

Public ContactVaidya Sushil Dubey

Banaras Hindu University

vaidyaskd@bhu.ac.in9415540732

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026